Page last updated: 2024-08-21

podophyllotoxin and aclarubicin

podophyllotoxin has been researched along with aclarubicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hansen, HF; Jensen, LH; Jensen, PB; Nitiss, JL; Rothenborg-Jensen, L; Schmidt, G; Sehested, M; Wessel, I	1

Other Studies

1 other study(ies) available for podophyllotoxin and aclarubicin

Article	Year
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines. Anti-cancer drug design, 2001, Volume: 16, Issue:6 Topics: Aclarubicin; Acridines; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Cell Survival; Cross-Linking Reagents; DNA; DNA Damage; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Mutation; Podophyllotoxin; Polymerase Chain Reaction; Razoxane; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2001

Article

Year

Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.

Anti-cancer drug design, 2001, Volume: 16, Issue:6

Topics: Aclarubicin; Acridines; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Cell Survival; Cross-Linking Reagents; DNA; DNA Damage; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Mutation; Podophyllotoxin; Polymerase Chain Reaction; Razoxane; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured

2001